Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Efficacy and safety of insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Chinese adults with type 2 diabetes: A phase III, open-label, 2:1 randomized, treat-to-target trial.

  • Authors : Yang W; China-Japan Friendship Hospital, Beijing, China.; Ma J

Subjects: Biphasic Insulins*/Biphasic Insulins*/Biphasic Insulins*/adverse effects ; Biphasic Insulins*/Biphasic Insulins*/Biphasic Insulins*/therapeutic use ; Hypoglycemic Agents*/Hypoglycemic Agents*/Hypoglycemic Agents*/adverse effects

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2019 Jul; Vol. 21 (7), pp. 1652-1660. Date of Electronic Publication: 2019 Apr 04.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Successful management of type IV hypersensitivity reactions to human insulin analogue with injecting mixtures of biphasic insulin aspart and dexamethasone.

  • Authors : Wen WL; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Tsai KB

Subjects: Dexamethasone/Dexamethasone/Dexamethasone/*therapeutic use ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hypersensitivity, Delayed/Hypersensitivity, Delayed/Hypersensitivity, Delayed/*chemically induced

  • Source: Journal of the Formosan Medical Association = Taiwan yi zhi [J Formos Med Assoc] 2019 Apr; Vol. 118 (4), pp. 843-848. Date of Electronic Publication: 2019 Jan 28.Publisher: Formosan Medical Association, Elsevier Country of Publication: Singapore NLM ID: 9214933 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Efficacy and safety of three-times-daily versus twice-daily biphasic insulin aspart 30 in patients with type 2 diabetes mellitus inadequately controlled with basal insulin combined with oral antidiabetic drugs.

  • Authors : Yang W; China-Japan Friendship Hospital, East Yinghuayuan Street, Hepingli, Beijing 100029, China. Electronic address: .; Ersoy C

Subjects: Biphasic Insulins/Biphasic Insulins/Biphasic Insulins/*therapeutic use ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hypoglycemia/Hypoglycemia/Hypoglycemia/*prevention & control

  • Source: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2019 Apr; Vol. 150, pp. 158-166. Date of Electronic Publication: 2019 Mar 11.Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8508335 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral antidiabetic drugs: The merit study.

  • Authors : Guo L; Department of Endocrinology, Beijing Hospital, National Center of Gerontology, Beijing, China.; Chen L

Subjects: Biphasic Insulins/Biphasic Insulins/Biphasic Insulins/*administration & dosage ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*administration & dosage

  • Source: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2018 Dec; Vol. 20 (12), pp. 2740-2747. Date of Electronic Publication: 2018 Aug 02.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883645 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Original paper: Efficacy and safety analysis of insulin degludec/insulin aspart compared with biphasic insulin aspart 30: A phase 3, multicentre, international, open-label, randomised, treat-to-target trial in patients with type 2 diabetes fasting during Ramadan.

  • Authors : Hassanein M; Endocrine Department, Dubai Hospital, Dubai Health Authority, Dubai, United Arab Emirates. Electronic address: .; Echtay AS

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Fasting/Fasting/Fasting/*blood ; Glycated Hemoglobin/Glycated Hemoglobin/Glycated Hemoglobin/*drug effects

  • Source: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2018 Jan; Vol. 135, pp. 218-226. Date of Electronic Publication: 2017 Nov 26.Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8508335 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

Insulin degludec/insulin aspart vs biphasic insulin aspart 30 twice daily in Japanese patients with type 2 diabetes: A randomized controlled trial.

  • Authors : Onishi Y; The Institute for Adult Diseases, Asahi Life Foundation, Tokyo, Japan.; Yamada K

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use ; Insulin Aspart/Insulin Aspart/Insulin Aspart/*therapeutic use

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2017 Mar; Vol. 8 (2), pp. 210-217. Date of Electronic Publication: 2016 Oct 07.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

Record details

×
Academic Journal

Management of postprandial glucose: Recommended targets and treatment with biphasic insulin.

  • Authors : Liebl A; Department of Internal Medicine, Centre for Diabetes and Metabolism, Fachklinik Bad Heilbrunn, Bad Heilbrunn, Germany. Electronic address: .

Subjects: Biphasic Insulins/Biphasic Insulins/Biphasic Insulins/*administration & dosage ; Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Diabetes Mellitus/Diabetes Mellitus/Diabetes Mellitus/*drug therapy

  • Source: Primary care diabetes [Prim Care Diabetes] 2016 Dec; Vol. 10 (6), pp. 391-397. Date of Electronic Publication: 2016 Jul 11.Publisher: Elsevier Country of Publication: England NLM ID: 101463825 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0210

Record details

×
Academic Journal

Twice-daily insulin degludec/insulin aspart provides superior fasting plasma glucose control and a reduced rate of hypoglycaemia compared with biphasic insulin aspart 30 in insulin-naïve adults with Type 2 diabetes.

  • Authors : Franek E; Mossakowski Medical Research Centre, Polish Academy of Sciences and Department of Internal Diseases, Endocrinology and Diabetology, Central Clinical Hospital MSW, Warsaw, Poland.; Haluzík M

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hyperglycemia/Hyperglycemia/Hyperglycemia/*prevention & control ; Hypoglycemia/Hypoglycemia/Hypoglycemia/*prevention & control

  • Source: Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2016 Apr; Vol. 33 (4), pp. 497-505. Date of Electronic Publication: 2015 Nov 17.Publisher: Blackwell Science Country of Publication: England NLM ID: 8500858 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Comparison of exenatide with biphasic insulin aspart 30 on glucose variability in type 2 diabetes: study protocol for a randomized controlled trial.

  • Authors : Xu S; Department of Endocrinology, Xijing Hospital, Fourth Military Medical University, 169 Changle Road West, Xi'an, 710032, China.; Liu X

Subjects: Biphasic Insulins/Biphasic Insulins/Biphasic Insulins/*therapeutic use ; Blood Glucose/Blood Glucose/Blood Glucose/*drug effects ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Trials [Trials] 2016 Mar 24; Vol. 17, pp. 160. Date of Electronic Publication: 2016 Mar 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

Record details

×
Academic Journal

Subject-driven titration of biphasic insulin aspart 30 twice daily is non-inferior to investigator-driven titration in Chinese patients with type 2 diabetes inadequately controlled with premixed human insulin: A randomized, open-label, parallel-group, multicenter trial.

  • Authors : Yang W; China-Japan Friendship Hospital Beijing China.; Zhu L

Subjects: Asian People*; Biphasic Insulins/Biphasic Insulins/Biphasic Insulins/*administration & dosage ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy

  • Source: Journal of diabetes investigation [J Diabetes Investig] 2016 Jan; Vol. 7 (1), pp. 85-93. Date of Electronic Publication: 2015 May 25.Publisher: Asian Association for the Study of Diabetes and Blackwell Pub. Asia Country of Publication: Japan NLM ID: 101520702 Publication Model:

Record details

×
  • 1-10 of  199 results for ""BIPHASIC insulin""